Sirtuin 5 调控近端小管脂肪酸氧化以抵御急性肾损伤
该研究在雄性 Sirt5 缺陷小鼠及分离的近端小管细胞中,采用缺血性和顺铂诱导两种 AKI 模型,发现 Sirt5 高表达于近端小管上皮细胞,其敲除虽轻度降低线粒体功能但显著增强过氧化物酶体脂肪酸氧化,且不引起明显肾脏表型;在两种 AKI 后,Sirt5 敲除小鼠肾功能显著改善、组织损伤减轻,伴随过氧化物酶体脂肪酸氧化高于线粒体。结论提示 Sirt5 通过调节线粒体与过氧化物酶体脂肪酸氧化平衡保护 AKI,可能成为治疗靶点。
要点
- Sirt5 在近端小管上皮细胞高表达,敲除后基线过氧化物酶体脂肪酸氧化显著增加。
- Sirt5 敲除小鼠在缺血或顺铂 AKI 后肾功能显著改善、组织损伤减轻。
- Sirt5 调控线粒体与过氧化物酶体脂肪酸氧化平衡,可能成为 AKI 治疗靶点。
核心结论
- Sirt5 通过调节近端小管上皮细胞线粒体与过氧化物酶体脂肪酸氧化平衡,保护缺血性和顺铂诱导的 AKI。
研究设计与样本
- 研究使用雄性 Sirt5 缺陷小鼠(+/- 或 -/-)及野生型对照,以及分离的近端小管细胞,建立缺血诱导和顺铂诱导两种 AKI 模型。
- 通过标准技术评估肾功能和损伤,并以 14C 标记棕榈酸酯分解为 14CO2 测定脂肪酸氧化。
主要发现
- Sirt5 在近端小管上皮细胞高表达;基线时 Sirt5-/- 小鼠线粒体功能轻度下降但过氧化物酶体脂肪酸氧化显著增加。
- Sirt5-/- 小鼠无 overt 肾脏表型,但在缺血或顺铂 AKI 后肾功能显著改善、组织损伤减轻。
- Sirt5-/- 近端小管上皮细胞中过氧化物酶体脂肪酸氧化高于线粒体脂肪酸氧化。
临床怎么用
- Sirt5 及其调控的过氧化物酶体脂肪酸氧化通路可能作为 AKI 治疗的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The primary site of damage during AKI, proximal tubular epithelial cells, are highly metabolically active, relying on fatty acids to meet their energy demands. These cells are rich in mitochondria and peroxisomes, the two organelles that mediate fatty acid oxidation. Emerging evidence shows that both fatty acid pathways are regulated by reversible posttranslational modifications, particularly by lysine acylation. Sirtuin 5 (Sirt5), which localizes to both mitochondria and peroxisomes, reverses post-translational lysine acylation on several enzymes involved in fatty acid oxidation. However, the role of the Sirt5 in regulating kidney energy metabolism has yet to be determined. METHODS: We subjected male Sirt5-deficient mice (either +/- or -/-) and wild-type controls, as well as isolated proximal tubule cells, to two different AKI models (ischemia-induced or cisplatin-induced AKI). We assessed kidney function and injury with standard techniques and measured fatty acid oxidation by the catabolism of 14C-labeled palmitate to 14CO2. RESULTS: Sirt5 was highly expressed in proximal tubular epithelial cells. At baseline, Sirt5 knockout (Sirt5-/- ) mice had modestly decreased mitochondrial function but significantly increased fatty acid oxidation, which was localized to the peroxisome. Although no overt kidney phenotype was observed in Sirt5-/- mice, Sirt5-/- mice had significantly improved kidney function and less tissue damage compared with controls after either ischemia-induced or cisplatin-induced AKI. This coincided with higher peroxisomal fatty acid oxidation compared with mitochondria fatty acid oxidation in the Sirt5-/- proximal tubular epithelial cells. CONCLUSIONS: Our findings indicate that Sirt5 regulates the balance of mitochondrial versus peroxisomal fatty acid oxidation in proximal tubular epithelial cells to protect against injury in AKI. This novel mechanism might be leveraged for developing AKI therapies.
引用
- Chiba T, Peasley KD, Cargill KR, et al. Sirtuin 5 Regulates Proximal Tubule Fatty Acid Oxidation to Protect against AKI. J Am Soc Nephrol. 2019. PMID: 31575700. doi:10.1681/ASN.2019020163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。